Nurexone Biologic Stock Probability of Future Stock Price Finishing Over 14.67
| NRX Stock | 0.77 0.02 2.53% |
NurExone |
NurExone Biologic Target Price Odds to finish over 14.67
The tendency of NurExone Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 14.67 or more in 90 days |
| 0.77 | 90 days | 14.67 | close to zero percent |
Based on a normal probability distribution, the odds of NurExone Biologic to move over 14.67 or more in 90 days from now is close to zero percent (This NurExone Biologic probability density function shows the probability of NurExone Stock to fall within a particular range of prices over 90 days) . Probability of NurExone Biologic price to stay between its current price of 0.77 and 14.67 at the end of the 90-day period is roughly 2.81 .
Assuming the 90 days horizon NurExone Biologic has a beta of -0.57. This indicates as returns on the benchmark increase, returns on holding NurExone Biologic are expected to decrease at a much lower rate. During a bear market, however, NurExone Biologic is likely to outperform the market. Additionally NurExone Biologic has an alpha of 0.6669, implying that it can generate a 0.67 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). NurExone Biologic Price Density |
| Price |
Predictive Modules for NurExone Biologic
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NurExone Biologic. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.NurExone Biologic Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NurExone Biologic is not an exception. The market had few large corrections towards the NurExone Biologic's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NurExone Biologic, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NurExone Biologic within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.67 | |
β | Beta against Dow Jones | -0.57 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | 0.11 |
NurExone Biologic Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NurExone Biologic for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NurExone Biologic can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NurExone Biologic has some characteristics of a very speculative penny stock | |
| NurExone Biologic appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (3.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NurExone Biologic generates negative cash flow from operations | |
| Latest headline from news.google.com: NurExone Reports Breakthrough in Vision Restoration - TipRanks |
NurExone Biologic Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NurExone Stock often depends not only on the future outlook of the current and potential NurExone Biologic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NurExone Biologic's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.2 M |
NurExone Biologic Technical Analysis
NurExone Biologic's future price can be derived by breaking down and analyzing its technical indicators over time. NurExone Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NurExone Biologic. In general, you should focus on analyzing NurExone Stock price patterns and their correlations with different microeconomic environments and drivers.
NurExone Biologic Predictive Forecast Models
NurExone Biologic's time-series forecasting models is one of many NurExone Biologic's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NurExone Biologic's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about NurExone Biologic
Checking the ongoing alerts about NurExone Biologic for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NurExone Biologic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NurExone Biologic has some characteristics of a very speculative penny stock | |
| NurExone Biologic appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (3.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NurExone Biologic generates negative cash flow from operations | |
| Latest headline from news.google.com: NurExone Reports Breakthrough in Vision Restoration - TipRanks |
Additional Tools for NurExone Stock Analysis
When running NurExone Biologic's price analysis, check to measure NurExone Biologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NurExone Biologic is operating at the current time. Most of NurExone Biologic's value examination focuses on studying past and present price action to predict the probability of NurExone Biologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NurExone Biologic's price. Additionally, you may evaluate how the addition of NurExone Biologic to your portfolios can decrease your overall portfolio volatility.